Search Within

Population Sciences Research Program

  1. "Behavioral Sciences Service"
  2. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (4)
Groups
  1. Behavioral Sciences Service (11)
  2. Department of Medicine (11)
  3. GSK Faculty (11)
  4. Human Oncology and Pathogenesis Program (11)
  5. Psychiatry and Behavioral Sciences, Department of (11)
  6. Solid Tumor Oncology Division (11)

More Groups

People
  1. Jada Hamilton (5)
  2. Michael Berger (5)
  3. Clifford Hudis (4)
  4. Diana Lake (4)
  5. Elyse Shuk (4)
  6. Gabriella D'Andrea-Carlino (4)

More People

Years
  1. 2024 (1)
  2. 2022 (2)
  3. 2019 (2)
  4. 2018 (1)
  5. 2017 (1)
  6. 2015 (2)

More Years

Publications
  1. Cancer Research (3)
  2. Cancer (2)
  3. Blood Advances (1)
  4. Cancer Epidemiology Biomarkers and Prevention (1)
  5. Clinical Breast Cancer (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Inc. (2)
  3. Wiley Blackwell (2)
  4. American Society of Clinical Oncology (1)
  5. American Society of Hematology (1)
  6. Springer Verlag (1)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in patients with endometrial cancer of diverse ancestry
    Journal Article

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants
    Journal Article

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Arnold, A. G.; Fleischut, M. H.; Latham, A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Stakeholders' perceptions and information needs regarding research medical donation
    Journal Article

    Epstein, A. S.; Hamilton, J. G.; Shuk, E.; Romano, D. R.; Lynch, K.; Khan, E.; Genoff, M.; Michael, C.; Iacobuzio-Donahue, C.
    Journal of Pain and Symptom Management (2019)

    Fulltext@MSK | Save
  • A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Reiner, A. S.; Buthorn, J. J.; Shuk, E.; Applebaum, A. J.; Hyman, D. M.; Abdel-Wahab, O.; Rampal, R.; Janku, F.; Brewer, K.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Stakeholders' perceptions and information needs regarding research medical donation (RMD)
    Meeting Abstract

    Epstein, A. S.; Shuk, E.; Romano, D. R.; Lynch, K.; Genoff, M.; Khan, E.; Iacobuzio-Donahue, C. A.; Hamilton, J. G.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Patient perspectives on ipilimumab across the melanoma treatment trajectory
    Journal Article

    Shuk, E.; Shoushtari, A. N.; Luke, J.; Postow, M. A.; Callahan, M.; Harding, J. J.; Roth, K. G.; Flavin, M.; Granobles, A.; Christian, J.; more...
    Supportive Care in Cancer (2017)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save